The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

Kiki M. H. Vangangelt(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Gabi W. van Pelt, Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Hein Putter, Isabelle M.F. Heemskerk(Leiden University Medical Center), Andrew R. Green(Nottingham Biomedical Research Centre), Marcelo Sobral‐Leite(The Netherlands Cancer Institute), Daniëlle Cohen(Royal Hallamshire Hospital), Marjanka K. Schmidt(University of Cambridge)
International Journal of Cancer
January 4, 2020
Cited by 72


Related Papers